MTH up +2.66% percent right now. $MTH High is at 38.47 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MTH up +2.66% percent right now. $MTH High is at 38.47 and the Low 37.24 with current volume of 215,934.

Recent News posted below.

MTH Meritage Corp Recent Headline News

Which Homebuilders Most Exposed To Texas Oil Risk?
at Investor's Business Daily - Mon Nov 10, 12:48PM CST
Sharply lower oil prices have sparked concerns that homebuilders in hot Texas markets may see cooler demand if jobs decline as a result, said Sterne Agee analyst Jay McCanless in a research report put out on Sunday. "Texas is a key market," he said,...
TMHC: 19.11 (+0.47), LEN: 46.53 (+1.24), SPF: 7.75 (+0.25), TPH: 15.05 (+0.27), BZH: 19.55 (+0.56), KBH: 17.03 (+0.57), MTH: 38.50 (+1.26)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Meritage Homes Is Up 3.3% (MTH)
Comtex SmarTrend(R) - Mon Nov 10, 8:50AM CST
12 days ago, on October 29th, 2014, Meritage Homes (NYSE:MTH) reported its earnings. Analysts, on average, expected earnings of $0.91 per share on sales of $575.3 million. The company actually reported EPS of $0.79 on sales of $562.3 million, missing EPS estimates by $0.11 and missing revenue estimates by $13.0 million. Since the company's report, shares of Meritage Homes have risen from $36.27 to $37.47, representing a gain of 3.3% in the past 12 days.
MTH: 38.50 (+1.26)

Meritage Homes (MTH) Downgraded From Buy to Hold
at The Street - Fri Oct 31, 8:34AM CDT
Meritage Homes MTH has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+
MTH: 38.50 (+1.26)

Meritage Homes (MTH) Down as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:55PM CDT
Meritage Homes Corporation (MTH) missed the Zacks Consensus Estimate for both earnings and revenues in the third quarter 2014.
PGTI: 9.75 (+0.04), HOV: 4.16 (+0.21), MTH: 38.50 (+1.26), NVR: 1,242.71 (+5.71)

Meritage Homes' (MTH) CEO Steven Hilton on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 5:40PM CDT

MTH: 38.50 (+1.26)

Meritage Homes Earnings: Making Progress in a Tough Housing Market
Jason Hall, The Motley Fool - Motley Fool - Wed Oct 29, 12:03PM CDT
Source: Meritage Homes. Leading homebuilder Meritage Homes  released its third-quarter earnings this morning. While it came up 12% short of analyst expectation for earnings per share, the company still made solid progress in one of the tougher...
MTH: 38.50 (+1.26)

Meritage misses Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
SCOTTSDALE, Ariz. (AP) _ Meritage Homes Corp. (MTH) on Wednesday reported third-quarter earnings of $32.6 million.
MTH: 38.50 (+1.26)

Meritage Homes misses by $0.11, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 7:20AM CDT

MTH: 38.50 (+1.26)

Meritage Homes Reports Results for the Third Quarter of 2014
Business Wire - Wed Oct 29, 7:01AM CDT
--Home closing revenue grew 13% on higher home closings and average prices
MTH: 38.50 (+1.26)

Notable earnings before Wednesday’s open
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:30PM CDT

AUO: 4.69 (-0.15), PSXP: 67.09 (-0.35), GHM: 32.97 (-1.01), CTCM: 6.15 (-0.04), HSY: 96.38 (-0.20), RYAM: 24.92 (-1.26), AIT: 49.55 (+0.15), AMED: 25.15 (+0.01), MRGE: 3.13 (-0.05), RL: 170.91 (-1.01), JLL: 140.92 (+0.90), CFR: 80.96 (-0.48), SPW: 92.74 (+0.01), CKSW: 7.37 (-0.07), IACI: 65.60 (-0.31), DXYN: 7.70 (+0.16), ROL: 32.32 (-0.15), NVMI: 10.60 (-0.15), PSX: 73.74 (-0.76), ETN: 68.32 (-1.06), RES: 15.68 (-0.03), HES: 83.70 (-0.11), EXC: 37.64 (+0.04), COT: 6.44 (-0.09), SEE: 38.25 (-0.50), VLY: 9.96 (-0.04), MHFI: 89.23 (-1.37), WLP: 126.72 (+1.22), UAM: 8.84 (-0.01), ADP: 84.82 (-0.30), PX: 126.74 (+0.37), STM: 6.90 (+0.02), CCJ: 19.36 (+0.16), ALLY: 22.72 (-0.06), GRMN: 55.70 (+0.12), SPWR: 29.33 (-1.07), PAG: 47.28 (+0.18), H: 58.20 (+0.80), WEC: 49.59 (-0.17), ARW: 57.75 (+0.19), CMC: 16.66 (-0.05), BDC: 71.58 (-0.33), TEL: 61.59 (+0.09), ACCO: 8.68 (-0.17), AVX: 13.98 (-0.08), LFUS: 98.20 (+0.31), BAH: 26.06 (+0.20), UBSI: 35.39 (-0.25), ALKS: 52.99 (+0.35), SO: 47.50 (-0.09), WM: 49.39 (-0.10), EVER: 18.96 (-0.06), ISSI: 13.82 (-0.09), GT: 25.20 (-0.13), SKYW: 12.35 (-0.01), TFX: 113.69 (-0.44), SODA: 21.71 (-0.04), MTH: 38.50 (+1.26), OMG: 27.00 (-0.29), PB: 60.33 (-0.35)

12.4% Return Seen to Date on SmarTrend Meritage Homes Call (MTH)
Comtex SmarTrend(R) - Tue Oct 14, 11:22AM CDT
SmarTrend identified a Downtrend for Meritage Homes (NYSE:MTH) on September 16th, 2014 at $38.92. In approximately 4 weeks, Meritage Homes has returned 12.41% as of today's recent price of $34.08.
MTH: 38.50 (+1.26)

Upgrade Alert for Meritage Homes (MTH)
Comtex SmarTrend(R) - Mon Oct 06, 6:56AM CDT
Meritage Homes (NYSE:MTH) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $35.92 on volume of 559,000 shares, above average daily volume of 490,000. Meritage Homes (NYSE:MTH) has potential upside of 32.4% based on a current price of $35.92 and analysts' consensus price target of $47.56. The stock should run into initial resistance at its 50-day moving average (MA) of $39.20 and subsequent resistance at its 200-day MA of $42.10.
MTH: 38.50 (+1.26)

Meritage Homes Third Quarter 2014 Earnings Release and Webcast Conference Call Scheduled for October 29, 2014
Business Wire - Wed Oct 01, 7:00AM CDT
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, plans to release the Company's third quarter 2014 results on Wednesday, October 29, 2014 before the market opens. Following the release, management will host a conference call to discuss their results at 7:30 a.m. Arizona Time (10:30 a.m. Eastern Time).
MTH: 38.50 (+1.26)

Meritage Homes Presentation to be Webcast on October 1 from Deutsche Bank Conference
Business Wire - Wed Sep 24, 1:28PM CDT
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, announced today that Meritage management will be speaking to investors at the Deutsche Bank 22nd Annual Leveraged Finance Conference in Scottsdale, Arizona on October 1, 2014 at 2:10 PM local time. The event will be webcast live and may be accessed through the "Investor Relations" page of the Meritage Homes website, http://investors.meritagehomes.com. Participants should access the webcast event page at least five minutes before the live event for the audio link and any accompanying materials. Archived versions of the presentations will be available on this site for 60 days following the presentation.
DB: 30.12 (+0.12), MTH: 38.50 (+1.26)

Operation Homefront Selects Three Veterans for Mortgage-Free Homes from Meritage Homes
Business Wire - Thu Sep 11, 1:20PM CDT
Operation Homefront and Meritage Homes Corporation (NYSE: MTH) have selected three military families to receive newly-built mortgage-free homes. The homes are located in Winter Springs, Florida; Lincoln, California; and Houston, Texas. Each one of the homes will be unveiled to the families in November during the week leading up to Veterans Day.
MTH: 38.50 (+1.26)

3 Homebuilder Stocks That Should Rise On Order Growth
at Investor's Business Daily - Tue Sep 09, 2:14PM CDT
As the housing market continues to improve, homebuilders are well positioned to rally through the year end on order growth acceleration and stable gross margins, according to an analyst. That news sent a group of homebuilding stocks modestly higher...
DHI: 23.98 (+0.55), MHO: 22.94 (+0.34), LEN: 46.53 (+1.24), MDC: 25.13 (+0.35), SPF: 7.75 (+0.25), PHM: 20.90 (+0.59), MTH: 38.50 (+1.26)

Downgrade Alert for Meritage Homes (MTH)
Comtex SmarTrend(R) - Tue Sep 09, 7:05AM CDT
Meritage Homes (NYSE:MTH) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $40.15 on volume of 273,000 shares, below average daily volume of 497,000. Over the past year, Meritage Homes has traded in a range of $37.19 to $50.28 and closed yesterday at $40.15, 8% above that low. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.2%.
MTH: 38.50 (+1.26)

How Chinese Investors Play U.S. Property Without Leaving Home
at The Street - Thu Sep 04, 11:41AM CDT
The Chinese real estate funds are investing in Simon Property Group and Meritage Homes, among other familiar names.
HST: 22.74 (-0.02), UDR: 30.48 (-0.13), SPG: 180.50 (-1.77), BXP: 127.60 (-0.69), PSA: 187.61 (-0.51), EXR: 58.43 (-0.22), PLD: 41.61 (-0.07), MTH: 38.50 (+1.26), EQR: 70.10 (-0.36)

Does Upbeat Housing Data Signal Better 2H for Homebuilders? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 11:49AM CDT
Does Upbeat Housing Data Signal Better 2H for Homebuilders? - Industry Outlook
DHI: 23.98 (+0.55), GFA: 1.76 (-0.01), LEN: 46.53 (+1.24), RYL: 38.33 (+1.18), BZH: 19.55 (+0.56), KBH: 17.03 (+0.57), HOV: 4.16 (+0.21), MTH: 38.50 (+1.26), TOL: 33.63 (+0.68), NVR: 1,242.71 (+5.71)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading